Invivoscribe, Inc., an industry pioneer and global leader in the field of precision diagnostics announces the launch of a fully integrated drug development engine. This new engine will combine with its in-house expertise in diagnostics development and worldwide access to patients and clinical testing capabilities to accelerate drug development. Invivoscribe's therapeutics division also announced today that the company has in-licensed technology involving a preclinical molecule and associated